0
0
0
0
1
2
3
$0
Is Vistra solid or fragile? The Finex Financial Health Scanner reads VST's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $17.7B |
|---|---|
| Net income | $944.0M |
| Operating margin | 10.7% |
| Net margin | 5.3% |
| Cash and investments | $6.4B |
| Total debt | $25.3B |
| Free cash flow | $1.3B |
| Revenue growth (1 year) | 3.0% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.